Overview
 |
Anita W. Asgar, MD, FSCAI
Moderator and Speaker
|
 |
Jason H. Rogers, MD, FSCAI
Moderator and Speaker
|
 |
Chad Kliger, MD, FSCAI
Speaker
|
 |
Paul Dennis Mahoney, MD, FSCAI
Speaker
|
 |
Gagan Singh, MD, FSCAI
Speaker
|
 |
Anene Ukaigwe, MD, FSCAI
Speaker
|
Welcome and Overview, Jason H. Rogers, MD, FSCAI
Clinical Case Example: Severe TR, Anene Ukaigwe, MD, FSCAI
Patient Selection for Tricusipd TEER, Chad Kliger, MD, FSCAI
Procedural Strategy and Planning for Tricusipd TEER, Paul Dennis Mahoney, MD, FSCAI
Challenging Imaging: When to Consider 3D ICE, Gagan Singh, MD, FSCAI
T-TEER and Device Leads: How to Manage, Anita W. Asgar, MD, FSCAI
Case Resolution, Anene Ukaigwe, MD, FSCAI
Discussion, All
Acknowledgement of Commercial Support
This activity is supported by an unrestricted educational grant from Abbott.
Learning Objectives
Upon completion of this activity, participants will be able to:
1. Select appropriate patients for tricuspid TEER.
2. Develop a procedural strategy for tricuspid TEER.
3. Use 3D ICE for tricuspid TEER.
4. Develop a strategy for the tricuspid TEER in the setting of device leads.
Disclosures
PLANNER
Anita Asgar: Abbott - Advisory Board; Medtronic - Advisory Board; Edwards Lifesciences - Consulting.
FACULTY
Anita Asgar: Abbott - Advisory Board; Medtronic - Advisory Board; Edwards Lifesciences - Consulting.
Chad Kliger: Medtronic - Advisory Board, Consulting, Speaker; Edwards Lifesciences - Advisory Board, Consulting.
Paul Mahoney: Abbott - Advisory Board, Consulting; Edwards Lifesciences - Advisory Board, Consulting; Medtronic - Advisory Board, Consulting; Boston Scientific Corp. - Advisory Board.
Jason Rogers: Abbott - Adviosry Board, PI.
Gagan Singh: Abbott - Consulting; Philips - Consulting.
Anene Ukaigwe: Boston Scientific Corp. - Speaker, Edwards Lifesciences - Adviosry Board, Speaker; Medtronic - Advisory Board, Speaker.
REVIEWER
Andrew Klein: No financial relationships with inelgible companies.
SCAI STAFF
Laura Porter: No financial relationships with inelgible companies.
Continuing Education Information
Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
SCAI designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful Completion
Watch the content and complete the evaluation to obtain credit.
Activity Timeline
Record date: May 2, 2025
Publish date: June 30, 2025
Retire date: April 17, 2026
SCAI's Independent Content
As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.
Planning Process
SCAI activities are developed by the SCAI planners prior to and independent of commercial support. Members of the Education Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.
Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins.
Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations.
All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.
All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.
SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. SCAI's educational content is free of marketing or sales of products or services.
Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education.
SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.
Copyright
© 2025 Society for Cardiovascular Angiography and Interventions (SCAI). All rights reserved.